Poslední aktualizace :
19/11/2024
Vasodilatans   Isosorbide dinitrate  
injekce
Stabilita roztoků Stabilita směsí Faktory ovlivňující stabilitu Kompatibilita Způsoby aplikace Odkazy pdf
   Chemický vzorec  

Obchodní název   Obchodní název     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Angsobide Malajsie
Cedocard Nizozemsko
Diniket Itálie
Dinit Finsko
Dinitrato de isosorbida Peru
Ekilbran Mexiko
Hadirax Mexiko
Isobid Peru
Isoket Egypt, Irsko, Lucembursko, Malajsie, MaÔarsko, Mexiko, NÏmecko, Peru, Polsko, Portugalsko, Rakousko, Saúdská Arábie, Spojené arabské emiráty, Švýcarsko, Velká Británie, Venezuela
Isonit Ekvádor, Peru
Isosorbida dinitrato Mexiko
Isosorbide dinitrate Irsko, Velká Británie
Nitrosid Finsko
Nitrosorbide Itálie
Risordan Francie
Sorbidilat Švýcarsko
Zanisor Mexiko
Odkazy   injekce   Odkazy : Isosorbide dinitrate  
typ uveřejnění
190 noviny Lee MG.
Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets.
Am J Hosp Pharm 1986 ; 43: 1945-1950.
350 noviny Martens HJ, De Goede PN, Van Loenen AC.
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Am J Hosp Pharm 1990 ; 47: 369-373.
1067 noviny Zeidler C, Dettmering D, Schrammel W, Spieteller M.
Compatibility of various drugs used in intensive care medicine in polyethylene, PVC and glass infusion containers.
EJHP 1999 ; 5: 106-110.
1102 noviny Cossum PA, Roberts MS.
Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems.
Eur J Clin Pharmacol 1981 ; 19: 181-185.
1147 noviny De Muynck C, Colardyn F, Remon JP.
Influence of intravenous administration set composition on the sorption of isosorbide dinitrate.
J Pharm Pharmacol 1991 ; 43: 601-604.
1148 noviny De Muynck C, Remon JP, Colardyn F.
The sorption of isosorbide dinitrate to intravenous delivery systems.
J Pharm Pharmacol 1988 ; 40: 601-604.
1161 noviny Allwood MC.
Sorption of parenteral nitrates during administration with a syringe pump and extension set.
Int J Pharm 1987 ; 39: 183-188.
1232 noviny Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236.
1332 noviny Lee MG, Fenton-May V.
Absorption of isosorbide dinitrate by PVC infusion bags and administration sets.
J Clin Hosp Pharm 1981 ; 6: 209-211.
1468 noviny Sautou V, Chopineau J, Gremeau I, Chevrier R, Bruneaux F.
Compatibility with medical plastics and stability of continuously and simultaneously infused isosorbide dinitrate and heparin.
Int J Pharm 1994 ; 107: 111-119.
2141 noviny Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM.
Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
J Antimicrob Chemother 2003 ; 51: 651-658.
2231 noviny de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3385 noviny Raverdi V, Ampe E, Hecq JD, Tulkens PM.
Stability and compatibility of vancomycin for administration by continuous infusion.
J Antimicrob Chemother 2013 ; 68: 1179-1182.
4374 noviny Lardinois B, Dimitriou A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq J-H, Galanti L.M.
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit.
Int J Pharm Compound 2020 ;24,1:64-68
4698 noviny Ayari G, D'Huart E, Vigneron J, Demoré B.
Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs.
Pharmaceutical Technology in Hospital Pharmacy 2022

  Mentions Légales